MonticelliML, BeghiE. Chronic symmetric polyneuropathy in the elderly. A field screening investigation in two regions of Italy: background and methods of assessment. The Italian General Practitioner Study Group (IGPSG). Neuroepidemiology1993; 12:96–105.
2.
BharuchaNE, BharuchaAE, BharuchaEP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology1991; 41:1315–7.
3.
MacDonaldBK, CockerellOC, SanderJWAS. The incidence and lifetime prevalence of neurological disorders in a prospective community based study in the United Kingdom. Brain2000; (in press).
4.
UmeharaF, KiwakiT, YoshikawaH. Deletion in chromosome 17p11.2 including the peripheral myelin protein-22 (PMP-22) gene in hereditary neuropathy with liability to pressure palsies. J Neurol Sci1995; 133:173–6.
5.
NukadaH, McMorranPD. Perivascular demyelination and intramyelinic oedema in reperfusion nerve injury. J Anat1994; 185:259–66.
6.
NukadaH, McMorranPD, ShimizuJ. Acute inflammatory demyelination in reperfusion nerve injury. Ann Neurol2000; 47:71–9.
7.
HughesRAC, CameronJS, HallSM. Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus – nerve biopsy and response to plasma exchange. J Neurol1982; 228:239–47.
8.
CreamJJ, HernJEC, HughesRAC. Mixed or immune complex cryoglobulinaemia and neuropathy. J Neurol Neurosurg Psychiatry1974; 37:82–97.
9.
DyckPJ, BersteadTJ, ConnDL. Non systemic vasculitic neuropathy. Brain1987; 110:843–54.
10.
DyckPJB, NorellJE, DyckPJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology2000; 53:2113–21.
Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology1991; 41:617–8.
15.
LunnMPT, ManjiH, ChoudharyPP. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south-east England. J Neurol Neurosurg Psychiatry1999; 66:269–71.
16.
McLeodJG, PollardJD, MacaskillP. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol1999; 46:910–2.
17.
DyckPJ, O'BrienPC, OviattKF. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol1982; 11:136–41.
18.
DyckPJ, DaubeJ, O'BrienP. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. New Engl J Med1986; 314:461–5.
19.
HahnAF, BoltonCF, PillayN. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind, sham-controlled, cross-over study. Brain1996; 119:1055–66.
20.
van DoornPA, BrandA, StrengersPF. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology1990; 40:209–12.
21.
HahnAF, BoltonCF, ZochodneD. Intravenous immunoglobulin treatment (IVIg) in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind placebo-controlled cross-over study. Brain1996; 119:1067–78.
22.
VermeulenM, van DoornPA, BrandA. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatry1993; 56:36–9.
23.
HankeyGJ, ToddAAM, YapPL. An ‘n of 1’ trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry1994; 57:1137.
24.
ChoudharyPP, HughesRAC. . Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Quart J Med1995; 88:493–502.
25.
DyckPJ, LitchyWJ, KratzKM. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol1994; 36:838–45.
26.
DyckPJ, O'BrienP, SwansonC. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology1985; 35:1173–6.
27.
ChoudharyPP, ThompsonN, HughesRAC. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol1995; 242:252–3.
GorsonKC, RopperAH, ClarkBD. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2a. Neurology1998; 50:84–7.
30.
MartinaI, van DoornPA, SchmitzPIM. Chronic motor neuropathies: response to interferon-β 1a after failure of conventional therapies. J Neurol Neurosurg Psychiatry1999; 66:197–201.
31.
HaddenRDM, SharrackB, BensaS. Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology1999; 53:57–61.
32.
BarnettMH, PollardJD, DaviesL. Cyclosporin A in resistant chronic inflammatory deyelinating poly-radiculoneuropathy. Muscle Nerve1998;454–60.
33.
HodgkinsonSJ, PollardJD, McLeodJG. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry1990; 53:327–30.
34.
MahattanakulW, CrawfordTO, GriffinJW. Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. J Neurol Neurosurg Psychiatry1996; 60:185–7.
OhSJ, JoyJL, KuruogluR. Chronic sensory demyelinating neuropathy: Chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry1992; 55:677–80.
44.
ChaudhryV, CorseAM, CornblathDR. Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol1993; 33:237–42.
45.
ComiG, AmadioS, GalardiG. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry1994; 57(Suppl.):35–7.
46.
LégerJ-M, Younes-ChennoufiAv, ChassandeB. Treatment with human immunoglobulin of multifocal motor neuropathy and of polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry1994; 57(Suppl.):46–9.
47.
Nobile-OrazioE, MeucciN, BarbieriS. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology1993; 43:537–44.
48.
Van den BergLH, FranssenH, WokkeJHJ. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain1998; 121:421–8.
49.
Van den BergLH, KerkhoffH, OeyPL. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulin: A double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatry1995; 59:248–52.
50.
YukiN, YamazakiM, KondoH. Treatment of multifocal motor neuropathy with a high dosage of intravenous immunoglobulin. Muscle Nerve1993; 16:220–1.
51.
KellyJJ, KyleRA, O'BrienPC. The prevalence of monoclonal gammopathy in peripheral neuropathy. Neurology1981; 31:1480–3.
52.
KakuDA, EnglandJD, SumnerAJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain1994; 117:941–7.
53.
TatumAH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol1993; 33:502–6.
54.
HaysAP, LatovN, TakatsuM. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti MAG IgM M protein. Neurology1987; 37:242–56.
55.
WillisonHJ, TrappBD, BacherJD. Demyelination induced by intraneural injection of human anti MAG antibodies. Muscle Nerve1988; 11:1169–76.
56.
WilsonHC, LunnMPT, ScheyS. Successful treatment of IgM paraproteinaemic neuropathy with fludarabine. J Neurol Neurosurg Psychiatry1999; 66:575–80.
57.
DyckPJ, LowPA, WindebankAJ. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. New Engl J Med1991; 325:1482–6.
58.
DalakasMC, QuarlesRH, FarrerRG. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol1996; 40:792–795.
59.
SaidG. Indications and value of nerve biopsy. Muscle Nerve2000; 22:1617–9.
60.
GabrielC, HughesRAC, HowardR. A prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry1998; 64:700.
61.
FagiusJ. Chronic cryptogenic polyneuropathy. The search for a cause. Acta Neurol Scandinav1983; 67:173–80.
NotermansNC, WokkeJHJ, FranssenH. Chronic idiopathic polyneuropathy presenting in middle or old age: A clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry1993; 56:1066–71.
64.
SindrupSH, JensenTS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain1999; 83:389–400.
65.
HaratiY, GoochC, SwensonM. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology1998; 50:1842–6.
66.
PareysonD. Charcot-Marie-Tooth Disease and related neuropathies: molecular basis for distinction and diagnosis. Muscle Nerve1999; 22:1498–509.
67.
DéjérineJ, SottasJ. Sur la névrite: interstitielle hypertrophique at progressive de l'enfance. C R Seances Soc Biolb Fil1893; 45:63–70.
